Spine Intervention—an Update on Injectable Biomaterials

A special issue of Medicina (ISSN 1648-9144).

Deadline for manuscript submissions: closed (8 August 2022) | Viewed by 3570

Special Issue Editors


E-Mail Website
Guest Editor
2nd Department of Radiology , Attikon University Hospital, National and Kapodistrian University of Athens , Greece
Interests: imaging; computed tomography; magnetic resonance; medical imaging; pain management; diagnostic radiology; diagnostic imaging; ultrasound imaging; hepatocellular carcinoma; ultrasonography; liver cancer imaging; interventional radiology; musculoskeletal imaging; spine; low back pain; back pain; neuroradiology; musculoskeletal sonography; elastography; spine research; rfa; intervertebral disk; interventional pain management; bone tumours; infiltration; ablation techniques; vertebroplasty; osteoid osteoma; osteoplasty
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
2nd Department of Radiology, University General Hospital "ATTIKON" Medical School, National and Kapodistrian University of Athens, Athens, Greece
Interests: interventional oncology; ablation; vertebral augmentation; MSK interventions
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Indications for percutaneous, minimally invasive techniques in the spine using injectable materials include, among others, treatment of vertebral fractures and back pain related to intervertebral discs, facet or sacroiliac joints, as well as post-traumatic regeneration of the spinal cord. The purpose of this Special Issue is to provide an inside view of different injectable biomaterials used for the treatment of spinal pathologies and to provide an introduction to the basic concepts and advancements in the field.

 

This Special Issue welcomes original articles presenting experimental and clinical studies as well as reviews of the literature describing the current state of the art.

 

Potential topics include but are not limited to:

Injectable biomaterials for vertebral fractures;

Injectable biomaterials for intervertebral disc degeneration/herniation;

Injectable biomaterials for facet joints pathology;

Injectable biomaterials for sacroiliac joints pathology;

Injectable biomaterials for the treatment of pain generators;

Injectable scaffold systems for the regeneration of the spinal cord

Prof. Dr. Alexis Kelekis
Dr. Dimitrios Filippiadis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • injectable
  • biomaterials
  • spine
  • vertebral fractures
  • intervertebral disc
  • facet joints
  • spinal cord
  • regeneration
  • hernia
  • sacroiliac joints

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

7 pages, 305 KiB  
Communication
Vertebral Augmentation: Is It Time to Get Past the Pain? A Consensus Statement from the Sardinia Spine and Stroke Congress
by Joshua A. Hirsch, Chiara Zini, Giovanni Carlo Anselmetti, Francisco Ardura, Douglas Beall, Matteo Bellini, Allan Brook, Alessandro Cianfoni, Olivier Clerk-Lamalice, Bassem Georgy, Gianluca Maestretti, Luigi Manfré, Mario Muto, Orlando Ortiz, Luca Saba, Alexis Kelekis, Dimitrios K. Filippiadis, Stefano Marcia and Salvatore Masala
Medicina 2022, 58(10), 1431; https://doi.org/10.3390/medicina58101431 - 11 Oct 2022
Cited by 3 | Viewed by 1666
Abstract
Vertebral augmentation has been used to treat painful vertebral compression fractures and metastatic lesions in millions of patients around the world. An international group of subject matter experts have considered the evidence, including but not limited to mortality. These considerations led them to [...] Read more.
Vertebral augmentation has been used to treat painful vertebral compression fractures and metastatic lesions in millions of patients around the world. An international group of subject matter experts have considered the evidence, including but not limited to mortality. These considerations led them to ask whether it is appropriate to allow the subjective measure of pain to so dominate the clinical decision of whether to proceed with augmentation. The discussions that ensued are related below. Full article
(This article belongs to the Special Issue Spine Intervention—an Update on Injectable Biomaterials)
6 pages, 1385 KiB  
Article
Navigation Guidance for Percutaneous Splanchnic Nerve Radiofrequency Neurolysis: Preliminary Results
by Stavros Grigoriadis, Dimitrios Filippiadis, Vasiliki Stamatopoulou, Efthimia Alexopoulou, Nikolaos Kelekis and Alexis Kelekis
Medicina 2022, 58(10), 1359; https://doi.org/10.3390/medicina58101359 - 28 Sep 2022
Cited by 2 | Viewed by 1298
Abstract
Background and Objectives: To describe preliminary results upon the application of the “Cube Navigation System” (CNS) for computed tomography (CT)-guided splanchnic nerve radiofrequency neurolysis. Materials and Methods: CT-guided splanchnic nerve neurolysis was performed in five patients; in all cases, neurolysis was [...] Read more.
Background and Objectives: To describe preliminary results upon the application of the “Cube Navigation System” (CNS) for computed tomography (CT)-guided splanchnic nerve radiofrequency neurolysis. Materials and Methods: CT-guided splanchnic nerve neurolysis was performed in five patients; in all cases, neurolysis was performed under CT guidance using the CNS. The mean patient age was 71.6 years (range 54–81 years; male/female: 5/0). Technical success, parameters of the neurolysis session and complications were evaluated. Technical success was defined as a needle position on the defined target. Session parameters included procedure time and number of scans. The CIRSE reporting system was used for complications’ classification and grading. Results: Technical success was obtained in all cases; in 1/5 patients, a slight correction in needle orientation was necessary. Mean procedure time was 12.4 min (range 8–19 min); an average of four CT scans was recorded in the five neurolysis sessions. There were no complications or material failures reported in the present study. Conclusions: Preliminary results of the present study show that computed tomography (CT)-guided splanchnic nerve radiofrequency neurolysis using the CNS is an accurate and time-efficient percutaneous procedure. More prospective and comparative studies with larger patient samples are necessary for verification of this system as well as for drawing broader conclusions. Full article
(This article belongs to the Special Issue Spine Intervention—an Update on Injectable Biomaterials)
Show Figures

Figure 1

Back to TopTop